mazindol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (35.29) | 18.7374 |
1990's | 17 (50.00) | 18.2507 |
2000's | 5 (14.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duchemin, AM; Gudehithlu, KP; Hadjiconstantinou, M; Neff, NH | 1 |
Alexander, GM; Brainard, L; Gordon, SW; Grothusen, JR; Schwartzman, RJ | 1 |
Cadet, JL; Fahn, S; Jackson-Lewis, V; Kostic, V; Levivier, M; Popilskis, S; Przedborski, S | 1 |
Crossman, AR; Graham, WC; Hill, DR; Sambrook, MA; Woodruff, GN | 1 |
Danias, P; Mytilineou, C; Nicklas, WJ; Ofori, S; Shen, J | 1 |
Goldstein, M; Jonsson, G; Luthman, J; Sundström, E | 1 |
Barker, JL; di Porzio, U; Kopin, IJ; Schinelli, S; Zuddas, A | 1 |
Debler, EA; Hashim, A; Lajtha, A; Sershen, H | 1 |
Delanney, LE; Forno, LS; Irwin, I; Langston, JW; Peroutka, SJ; Ricaurte, GA | 1 |
Donnan, GA; Figdor, R; Kaczmarczyk, SJ; Mendelsohn, FA; Rowe, PJ | 1 |
Hashim, A; Lajtha, A; Mason, MF; Reith, ME; Sershen, H | 1 |
Heikkila, RE; Saari, WS; Youngster, SK | 1 |
Donnan, GA; Kaczmarczyk, SJ; Kalnins, RM; McKenzie, JS; Mendelsohn, FA; Rowe, PJ | 1 |
Carlsson, A; Pileblad, E | 1 |
Hashim, A; Lajtha, A; Reith, ME; Sershen, H | 1 |
Brooks, JD; DeLanney, LE; Irwin, I; Langston, JW; Ricaurte, GA | 1 |
Gnanalingham, KK; Hunter, AJ; Jenner, P; Marsden, CD; Milkowski, NA; Smith, LA | 1 |
Jenner, P; Jolkkonen, J; Marsden, CD | 1 |
Frohna, PA; Joyce, JN; Rothblat, DS; Schneider, JS | 1 |
Chan, P; Di Monte, DA; Langston, JW | 1 |
Audet, G; Parent, A; Pedneault, S; Soghomonian, JJ | 1 |
Gnanalingham, KK; Hunter, AJ; Jenner, P; Marsden, CD; Smith, LA | 1 |
Chan, P; DeLanney, LE; Di Monte, DA; Irwin, I; Langston, JW | 1 |
DeLanney, LE; Graybiel, AM; Irwin, I; Langston, JW; Moratalla, R; Quinn, B | 1 |
Hattori, T; Sugimoto, T; Takada, M | 1 |
Bennett, JP; Jung, AB; Smith, TS; Trimmer, PA | 1 |
Ali, SF; Itzhak, Y; Martin, JL; Norenberg, MD | 1 |
Araki, T; Fujihara, K; Itoyama, Y; Nagasawa, H; Tanji, H | 1 |
Pope-Coleman, A; Schneider, JS; Tinker, JP | 1 |
Costa, S; Jenner, P; Marsden, CD; Pearce, RK | 1 |
Schneider, JS; Wade, TV | 1 |
Chen, JF; Schwarzschild, MA; Xu, K; Xu, YH | 1 |
Jenner, P; Kunikowska, G | 1 |
Baudry, M; Fonck, C | 1 |
1 review(s) available for mazindol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain Chemistry; Carotid Arteries; Corpus Striatum; Disease Models, Animal; Female; Macaca mulatta; Male; Mazindol; Parkinson Disease, Secondary; Receptors, Dopamine; Substantia Nigra | 1991 |
33 other study(ies) available for mazindol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
c-fos mRNA in mouse brain after MPTP treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blotting, Northern; Brain; Dose-Response Relationship, Drug; Genes, fos; Kinetics; Male; Mazindol; Mice; Neurotoxins; Organ Specificity; Pargyline; Reference Values; RNA; RNA, Messenger; Selegiline; Time Factors | 1992 |
Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Catecholamines; Dopamine; Dopamine Agents; Levodopa; Macaca fascicularis; Male; Mazindol; Parkinson Disease, Secondary; Receptors, Dopamine | 1992 |
Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Benzodiazepinones; Cholecystokinin; Devazepide; Indicators and Reagents; Iodine Radioisotopes; Macaca fascicularis; Mazindol; Parkinson Disease, Secondary; Prosencephalon; Receptors, Cholecystokinin; Sincalide; Substantia Nigra; Succinimides; Sulpiride; Tegmentum Mesencephali; Tritium | 1991 |
Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Designer Drugs; Dopamine; Embryo, Mammalian; Isoenzymes; Kinetics; Mazindol; Mesencephalon; Monoamine Oxidase; Neurons; Neurotoxins; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reserpine; Rotenone; Time Factors | 1989 |
Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Hydroxydopamines; Male; Mazindol; Mice; Mice, Inbred C57BL; Nerve Degeneration; Pyridines; Substantia Nigra; Tyrosine 3-Monooxygenase | 1988 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Astrocytes; Cells, Cultured; Dopamine; Kinetics; Mazindol; Mesencephalon; Mice; Neurons; Pyridines; Pyridinium Compounds; Tetrodotoxin; Veratridine | 1988 |
Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ascorbic Acid; Biological Transport; Cocaine; Corpus Striatum; Dopamine; Kinetics; Mazindol; Mice; Nicotine; Piperazines; Pyridines; Synaptosomes | 1988 |
Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Male; Mazindol; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Endings; Neurochemistry; Neurons; Pyridines; Substantia Nigra; Tritium | 1986 |
The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Kinetics; Mazindol; Mice; Mice, Inbred C57BL; Pyridines | 1986 |
Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Membrane; Corpus Striatum; Dextroamphetamine; Dopamine; Drug Synergism; Female; Mazindol; Mice; Mice, Inbred BALB C; Nicotine; Pyridines | 1986 |
1-Methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine (MCTP): an alicyclic MPTP-like neurotoxin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caudate Nucleus; Dopamine; Indans; Male; Mazindol; Mice; Mice, Inbred BALB C; Putamen; Pyridines; Synaptosomes | 1987 |
Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Dopamine; Injections, Intraperitoneal; Mazindol; Mice; Mice, Inbred C57BL; Pyridines; Receptors, Dopamine; Time Factors | 1987 |
Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Catecholamines; Male; Maprotiline; Mazindol; Mice; Nervous System Diseases; Pyridines | 1985 |
Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ascorbic Acid; Corpus Striatum; Mazindol; Mice; Mice, Inbred BALB C; Nervous System; Pyridines; Synaptosomes | 1985 |
Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benztropine; Bupropion; Corpus Striatum; Dopamine; Male; Mazindol; Mice; Mice, Inbred C57BL; Nalidixic Acid; Naphthyridines; Parasympatholytics; Propiophenones; Pyridines; Receptors, Dopamine | 1985 |
Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Autoradiography; Callithrix; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Frontal Lobe; Globus Pallidus; Male; Mazindol; Nucleus Accumbens; Parkinson Disease; Putamen; Substantia Nigra; Tissue Distribution; Ventral Tegmental Area | 1995 |
L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Callithrix; Caudate Nucleus; Enkephalins; Female; Gene Expression; In Situ Hybridization; Levodopa; Male; Mazindol; Motor Activity; Nucleus Accumbens; Putamen; RNA, Messenger; Substance P | 1995 |
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Cats; Corpus Striatum; Mazindol; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 1995 |
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain Chemistry; Deoxyglucose; Energy Metabolism; Glutamic Acid; Male; Mazindol; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Selegiline | 1994 |
Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Axons; Corpus Striatum; Gene Expression Regulation; Globus Pallidus; Glutamate Decarboxylase; Mazindol; Parkinson Disease, Secondary; Putamen; Radiography; RNA, Messenger; Saimiri | 1994 |
Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Benzazepines; Brain; Callithrix; Corpus Striatum; Female; Male; Mazindol; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Tissue Distribution | 1993 |
2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Brain; Cerebellar Cortex; Deoxyglucose; Drug Interactions; Male; Mazindol; Mice; Mice, Inbred C57BL; Pyridinium Compounds | 1993 |
Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain Mapping; Caudate Nucleus; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Injections, Subcutaneous; Mazindol; Neural Pathways; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine; Saimiri; Substantia Nigra | 1993 |
MPTP neurotoxicity to cerebellar Purkinje cells in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benztropine; Dose-Response Relationship, Drug; Male; Mazindol; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; MPTP Poisoning; Neurotoxins; Pargyline; Purkinje Cells; Selegiline | 1993 |
Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Corpus Striatum; Dopamine; Genes, p53; Immunohistochemistry; Mazindol; Mice; Mice, Knockout; Mice, Transgenic; Neurons; Neurotoxins; Substantia Nigra; Tyrosine 3-Monooxygenase | 1996 |
Depletion of striatal dopamine transporter does not affect psychostimulant-induced locomotor activity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Central Nervous System Stimulants; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kinetics; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Motor Activity; Neostriatum; Nerve Tissue Proteins; Protein Binding | 1997 |
Alteration of neurotensin receptors in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Male; Mazindol; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurotensin; Neurotoxins; Parkinson Disease; Receptors, Neurotensin; Substantia Nigra | 1999 |
Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Binding Sites; Dopamine Agents; Dopamine Antagonists; Dopamine Uptake Inhibitors; G(M1) Ganglioside; Mazindol; Neostriatum; Parkinsonian Disorders; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Recovery of Function; Saimiri; Spiperone; Synapses | 2000 |
Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Derived Neurotrophic Factor; Callithrix; Dopamine Agents; Dopamine Uptake Inhibitors; Glutamate Decarboxylase; Mazindol; Motor Activity; Parkinsonian Disorders; Striatonigral Degeneration; Substantia Nigra; Tyrosine 3-Monooxygenase | 1999 |
Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Cognition Disorders; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; In Situ Hybridization; Macaca; Male; Mazindol; Parkinson Disease, Secondary; Predictive Value of Tests; Protein Precursors; RNA, Messenger; Severity of Illness Index; Tachykinins; Tritium | 2001 |
Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Caffeine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Tolerance; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Tritium | 2002 |
Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Animals; Autoradiography; Basal Ganglia; Brain Mapping; Callithrix; Female; Glutathione Peroxidase; Humans; In Situ Hybridization; Male; Mazindol; Neural Pathways; Parkinson Disease; RNA, Messenger; Substantia Nigra; Superoxide Dismutase; Tissue Distribution; Tritium | 2003 |
Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Antioxidants; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclic N-Oxides; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Free Radicals; In Vitro Techniques; Male; Mazindol; Mitochondria; Neostriatum; Nitrogen Oxides; Organometallic Compounds; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Rotenone; Salicylates; Subcellular Fractions; Synaptosomes; Uncoupling Agents | 2003 |